Video
Online tool demonstrates potential for prostate cancer medication cost savings
Author(s):
“It's a really simple tool to predict your out-of-pocket costs,” says Benjamin Pockros, MD, MBA, of Medicare Plan Finder.
Video Player is loading.
In this interview, Benjamin Pockros, MD, MBA, discusses the presentation “Out-Of-Pocket Costs for Prostate Cancer Medications Substantially Vary by Part D Plan: An Online Tool Could Save Patients Thousands of Dollars,” which he gave at the 2022 Society of Urologic Oncology Annual Meeting in San Diego, California. Pockros is a urology resident at the University of Michigan, Ann Arbor.
Related Videos
Gopa Iyer, MD, highlights findings from FORAGER-1 in metastatic urothelial carcinoma
Michael Schweizer, MD, shares data on mevrometostat plus enzalutamide in mCRPC
Laura Bukavina, MD, highlights study of urinary microbiome profiling
Kate Gessner, MD, on the mechanisms of immunotherapy failure in RCC
Darren Feldman, MD, on clinical outcomes in R/R testicular germ cell tumors
ASCO GU recap: Insights on 5 key trials
Laurence Albiges, MD, on COSMIC-313 trial of triplet vs doublet combination in aRCC
Francesca Jackson-Spence, MRCP, on efficacy of savolitinib/durvalumab in papillary renal cancer
Gopa Iyer, MD, on durable efficacy of EV/pembrolizumab in urothelial carcinoma
David Braun, MD, on phase 2 trial of an individualized neoantigen therapy for RCC
Related Content
